In the present study, we mainly focused on metabolite Neu5Ac and confirmed that the levels of Neu5Ac in hyperlipidemia patients as well as ApoE-/- mice were both up-regulated and displayed as an important risk factor in circulation for EC injury and AS progression. This evidence concerns the gene APOE and hyperlipidemia.